CYCLOSPORINE (CSA) ELIMINATES THE INCREASED RISK IN HIGH-RISK RENAL-TRANSPLANT RECIPIENTS (RTR)

被引：0
|
作者：
HADDAD, F
MACDONELL, RC
ELEZZ, A
RICHIE, RE
JOHNSON, HK
YNARES, C
VANBUREN, D
TRUSLER, L
NYLANDER, W
HELDERMAN, JH
CROWE, D
机构：
[1] VAMC,CTR RENAL TRANSPLANT,NASHVILLE,TN
[2] VANDERBILT UNIV,MED CTR,NASHVILLE,TN
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1995年 / 6卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1089 / 1089
页数：1
相关论文
共 50 条
  • [31] TUBULAR CHANGES IN RENAL-TRANSPLANT RECIPIENTS ON CYCLOSPORINE
    THIRU, S
    MAHER, ER
    HAMILTON, DV
    EVANS, DB
    CALNE, RY
    [J]. TRANSPLANTATION PROCEEDINGS, 1983, 15 (04) : 2846 - 2851
  • [32] USE OF CYCLOSPORINE IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
    CONLEY, SB
    FLECHNER, SM
    ROSE, G
    VANBUREN, CT
    BREWER, E
    KAHAN, BD
    [J]. JOURNAL OF PEDIATRICS, 1985, 106 (01): : 45 - 49
  • [33] PHARMACOKINETICS AND NEPHROTOXICITY OF CYCLOSPORINE IN RENAL-TRANSPLANT RECIPIENTS
    HENNY, FC
    KLEINBLOESEM, CH
    MOOLENAAR, AJ
    PAUL, LC
    BREIMER, DD
    VANES, LA
    [J]. TRANSPLANTATION, 1985, 40 (03) : 261 - 265
  • [34] STOPPING PREDNISONE (P) IN RENAL-TRANSPLANT (RT) RECIPIENTS TAKING CYCLOSPORINE (CSA) - SAFETY CONDITIONS
    LLOVERAS, J
    CUEVAS, X
    ORFILA, A
    MIR, M
    AUBIA, J
    MASRAMON, J
    [J]. KIDNEY INTERNATIONAL, 1987, 32 (04) : 617 - 618
  • [35] Mycophenolate mofetil immunosuppression in high-risk renal transplant recipients
    Abouna, GM
    Al Arrayed, AS
    Farid, E
    Awad, CK
    Sharqawi, SAD
    Tantawi, M
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) : 4077 - 4078
  • [36] Enhanced ATP secretion in platelets from tacrolimus (TACRO) and cyclosporine (CSA)-treated renal transplant recipients (RTR's)
    Salifu, MO
    Markell, MS
    Babinska, A
    Pervez, N
    Kornecki, E
    [J]. FASEB JOURNAL, 2000, 14 (04): : A187 - A187
  • [37] Selective cellcept therapy in high-risk renal transplant recipients
    Isenberg, A
    Singh, TP
    Shen, GK
    Freed, BM
    Conti, DJ
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1188 - 1189
  • [38] RISK INDICATORS OF DENOVO MALIGNANCY IN RENAL-TRANSPLANT RECIPIENTS
    SLOAN, GM
    COLE, P
    WILSON, RE
    [J]. TRANSPLANTATION PROCEEDINGS, 1977, 9 (01) : 1129 - 1132
  • [39] Cyclosporine (CSA) area under the curve (AUG) measurements do not predict biopsy (BX) proven CSA nephrotoxicity in renal transplant recipients (RTR).
    Steiner, RW
    Michel, DM
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3348 - A3348
  • [40] EFFECTS OF THE PROSTACYCLIN-ANALOG ILOPROST ON CYCLOSPORINE (CSA)-INDUCED RENAL HYPOPERFUSION IN STABLE RENAL-TRANSPLANT RECIPIENTS
    HANSEN, JM
    CHRISTENSEN, NJ
    FOGHANDERSEN, N
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 998 - 998
12345